speb/financial-data huggingface dataset:
Financial ratios for ALDX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -35265206
Net income: -33846661
Capital expenditures: 0
Operating cash flow: -33345682
Depreciation & amortization: 251993
Net tangible assets: 44250390
Owner earnings: -33594668
Return on net tangible assets (%): -75.91948455143559
Buffett classification: The Gruesome
Stock price: 5.18
Shares outstanding: 60321068
Book value: 44250390
P/B ratio: 7.061251488178973
Market cap (USD): 312463132.24
Debt to equity: 0.3509611779692789
Current ratio: 2.5813098074585907
Quick ratio: 2.5813098074585907
Interest coverage ratio: -18.50890721194976
Free cash flow (dilution-adjusted): -39437095
Buyback yield (%): 0
Retained earnings: -483957253
Capitalized R&D asset: 67694843.58
ROCI (R&D-adjusted, %): -39.35061689653763
Rule of 40 score: 0
Financial ratios for ALL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 106.26
Shares outstanding: 257420930
Market cap (USD): 27353548021.800003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALL — annual report dated 2022-12-31
Total revenue: 50617000000
Net income: -1289000000
Capital expenditures: 211000000
Operating cash flow: 5121000000
Depreciation & amortization: 847000000
Net tangible assets: 12809000000
Owner earnings: -653000000
Return on net tangible assets (%): -5.097977984229838
Buffett classification: The Gruesome
Stock price: 125.78
Shares outstanding: 257420930
Book value: 17363000000
P/B ratio: 1.8647932140413521
Market cap (USD): 32378404575.4
Debt to equity: 0.4586764959972355
COGS to revenue (%): 0
SG&A to revenue (%): 0.22917201730643855
Free cash flow (dilution-adjusted): 4701000000
Buyback yield (%): 7.782965322246326
Retained earnings: 50970000000
Receivables turnover: 2.6946869676320273
Capitalized R&D asset: 0
FCF margin (%): 9.287393563427306
Rule of 40 score: 9.287393563427306
Financial ratios for ALL — annual report dated 2023-12-31
Total revenue: 56591000000
Net income: -188000000
Capital expenditures: 240000000
Operating cash flow: 4228000000
Depreciation & amortization: 704000000
Net tangible assets: 13302000000
Owner earnings: 276000000
Buffett classification: The Gruesome
Stock price: 133.8
Shares outstanding: 257420930
Book value: 17630000000
P/B ratio: 1.9536540234827002
Market cap (USD): 34442920434
Debt to equity: 0.450482132728304
COGS to revenue (%): 0
SG&A to revenue (%): 0.015903588909897334
Free cash flow (dilution-adjusted): 3961000000
Buyback yield (%): 2.6420523827059164
Retained earnings: 49716000000
Receivables turnover: 3.001697342597995
Capitalized R&D asset: 0
FCF margin (%): 6.99934618578926
Revenue growth (%): 11.802358891281585
Rule of 40 score: 18.801705077070846
Financial ratios for ALL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 184.24
Shares outstanding: 257420930
Market cap (USD): 47427232143.200005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALL — annual report dated 2024-12-31
Total revenue: 63515000000
Net income: 4667000000
Capital expenditures: 192000000
Operating cash flow: 8931000000
Depreciation & amortization: 555000000
Net tangible assets: 17443000000
Owner earnings: 5030000000
Return on net tangible assets (%): 28.836782663532652
Buffett classification: The Gruesome
Stock price: 188.13
P/E ratio: 10.376815847632312
Shares outstanding: 257420930
Book value: 21367000000
P/B ratio: 2.266513762385922
Market cap (USD): 48428599560.9
Debt to equity: 0.3783872326484766
Effective tax rate (%): 20.17010935601458
COGS to revenue (%): 0
SG&A to revenue (%): -0.058253955758482245
Free cash flow (dilution-adjusted): 8721000000
Buyback yield (%): 0.004129791111314208
Retained earnings: 53288000000
Receivables turnover: 3.2508445081379875
Capitalized R&D asset: 0
FCF margin (%): 13.730614815397937
Revenue growth (%): 12.235161068014348
Rule of 40 score: 25.965775883412284
Financial ratios for ALL — quarterly report dated 2024-12-31
Capital expenditures: 50000000
Buffett classification: The Gruesome
Stock price: 188.13
Shares outstanding: 257420930
Market cap (USD): 48428599560.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALL — quarterly report dated 2025-03-31
Total revenue: 16263000000
Net income: 596000000
Capital expenditures: 92000000
Operating cash flow: 1964000000
Depreciation & amortization: 132000000
Net tangible assets: 18940000000
Owner earnings: 636000000
Return on net tangible assets (%): 3.357972544878564
Buffett classification: The Gruesome
Stock price: 203.07
P/E ratio: 21.927209838548656
Shares outstanding: 257420930
Book value: 22052000000
P/B ratio: 2.37050917173499
Market cap (USD): 52274468255.1
Debt to equity: 0.36667875929620897
Effective tax rate (%): 17.10709318497914
COGS to revenue (%): 0
SG&A to revenue (%): 0.4796163069544364
Free cash flow (dilution-adjusted): 1872000000
Buyback yield (%): 0.18938499673852038
Retained earnings: 53586000000
Receivables turnover: 0.7691543700340522
Capitalized R&D asset: 0
FCF margin (%): 11.510791366906476
Rule of 40 score: 11.510791366906476
Financial ratios for ALL — quarterly report dated 2025-06-30
Total revenue: 16546000000
Net income: 2109000000
Capital expenditures: 1000000
Operating cash flow: 1873000000
Depreciation & amortization: 127000000
Net tangible assets: 20901000000
Owner earnings: 2235000000
Return on net tangible assets (%): 10.69326826467633
Buffett classification: The Gruesome
Stock price: 198.38
P/E ratio: 18.878803731386324
Shares outstanding: 257420930
Book value: 24005000000
P/B ratio: 2.127355304869819
Market cap (USD): 51067164093.4
Debt to equity: 0.336888148302437
Effective tax rate (%): 22.345541990381058
COGS to revenue (%): 0
SG&A to revenue (%): 0
Free cash flow (dilution-adjusted): 1874000000
Buyback yield (%): 0.6657898593666808
Retained earnings: 55400000000
Receivables turnover: 0.7910690380569899
Capitalized R&D asset: 0
FCF margin (%): 11.326000241750272
Revenue growth (%): 1.7401463444628913
Rule of 40 score: 13.066146586213163
Financial ratios for ALL — quarterly report dated 2025-09-30
Total revenue: 17061000000
Net income: 3746000000
Capital expenditures: 48000000
Operating cash flow: 3284000000
Depreciation & amortization: 115000000
Net tangible assets: 24387000000
Owner earnings: 3813000000
Return on net tangible assets (%): 15.635379505474228
Buffett classification: The Gruesome
Stock price: 212.57
P/E ratio: 8.482400727034568
Shares outstanding: 257420930
Book value: 27489000000
P/B ratio: 1.9906132303867001
Market cap (USD): 54719967090.1
Debt to equity: 0.2942631598093783
Effective tax rate (%): 22.30753268312928
COGS to revenue (%): 0
SG&A to revenue (%): -0.6330226833128186
Free cash flow (dilution-adjusted): 3236000000
Buyback yield (%): 0.6578951325157716
Retained earnings: 58853000000
Receivables turnover: 0.802341986455982
Capitalized R&D asset: 0
FCF margin (%): 18.96723521481742
Revenue growth (%): 3.1125347516015958
Rule of 40 score: 22.07976996641902
Financial ratios for ALL — quarterly report dated 2025-12-31
Total revenue: 17199000000
Net income: 3832000000
Capital expenditures: 89000000
Operating cash flow: 2989000000
Depreciation & amortization: 108000000
Net tangible assets: 26934000000
Owner earnings: 3851000000
Return on net tangible assets (%): 14.297913417984704
Buffett classification: The Gruesome
Stock price: 207.1
P/E ratio: 5.184467042983565
Shares outstanding: 257420930
Book value: 30589000000
P/B ratio: 1.7428446370590736
Market cap (USD): 53311874603
Debt to equity: 0.24485926313380627
Effective tax rate (%): 22.136317395727364
COGS to revenue (%): 0
SG&A to revenue (%): -0.02907145764288621
Free cash flow (dilution-adjusted): 2900000000
Buyback yield (%): 0.8140775450720648
Retained earnings: 62393000000
Receivables turnover: 0.861026282853567
Capitalized R&D asset: 0
FCF margin (%): 16.861445432874003
Revenue growth (%): 0.8088623175663794
Rule of 40 score: 17.670307750440383
Financial ratios for ALL — annual report dated 2025-12-31
Total revenue: 67069000000
Net income: 10282000000
Capital expenditures: 228000000
Operating cash flow: 10110000000
Depreciation & amortization: 482000000
Net tangible assets: 26934000000
Owner earnings: 10536000000
Return on net tangible assets (%): 39.117843617732234
Buffett classification: The Gruesome
Stock price: 207.1
P/E ratio: 5.18497127047267
Shares outstanding: 257420930
Book value: 30589000000
P/B ratio: 1.7428446370590736
Market cap (USD): 53311874603
Debt to equity: 0.24485926313380627
Effective tax rate (%): 21.967163271511097
COGS to revenue (%): 0
SG&A to revenue (%): -0.05218506314392641
Free cash flow (dilution-adjusted): 9882000000
Buyback yield (%): 2.312805560078009
Retained earnings: 62393000000
Receivables turnover: 3.357647058823529
Capitalized R&D asset: 0
FCF margin (%): 14.734079828236593
Revenue growth (%): 5.595528615287727
Rule of 40 score: 20.32960844352432
Financial ratios for ALMGI.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.772727272727272
Shares outstanding: 5160046
Market cap (USD): 60747814.272727266
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALMGI.PA — annual report dated 2022-12-31
Total revenue: 88176053.19148937
Gross profit: 29070401.063829787
Operating income: 8346585.106382979
Net income: 7076397.872340426
Capital expenditures: 1094680.8510638298
Operating cash flow: -15794680.85106383
Depreciation & amortization: 1122589.3617021276
Net tangible assets: 24891230.851063833
Owner earnings: 7104306.382978723
Return on net tangible assets (%): 28.541402494264723
Capex to operating income (%): 13.115314072897693
Buffett classification: The Great
Stock price: 6.765957446808511
P/E ratio: 4.933675619913606
Shares outstanding: 5160046
Book value: 32865698.936170217
P/B ratio: 1.062282342675253
Market cap (USD): 34912651.65957447
Debt to equity: 0.1136085520449973
Current ratio: 2.4291321235262573
Quick ratio: 0.46212674760754063
Effective tax rate (%): 13.363376700847512
Interest coverage ratio: 160.11816326530612
COGS to revenue (%): 67.03141044349258
SG&A to revenue (%): 12.139457702427771
Free cash flow (dilution-adjusted): -16889361.70212766
Buyback yield (%): 0
Retained earnings: 22423120.21276596
Inventory turnover: 1.7764363925591844
Receivables turnover: 19.902250596631777
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.0639675778585
FCF margin (%): -19.15413662873924
Rule of 40 score: -19.15413662873924
Financial ratios for ALMGI.PA — annual report dated 2023-12-31
Total revenue: 78289722.22222222
Gross profit: 25040453.333333332
Operating income: 5048885.555555555
Net income: 4388560
Capital expenditures: 983333.3333333333
Operating cash flow: 7464444.444444444
Depreciation & amortization: 1268115.5555555555
Net tangible assets: 28556558.888888888
Owner earnings: 4673342.222222223
Return on net tangible assets (%): 16.365214872022204
Capex to operating income (%): 19.476245252802766
Buffett classification: The Great
Stock price: 5.8999999999999995
P/E ratio: 6.937189283045007
Shares outstanding: 5160046
Book value: 36763225.55555555
P/B ratio: 0.828117526140177
Market cap (USD): 30444271.4
Debt to equity: 0.0888502922138104
Current ratio: 6.058193004417394
Quick ratio: 2.1824683218622645
Effective tax rate (%): 8.018007464839867
Interest coverage ratio: 23.790560209424083
COGS to revenue (%): 68.01565694375947
Free cash flow (dilution-adjusted): 6481111.111111111
Buyback yield (%): 0
Retained earnings: 25856532.22222222
Inventory turnover: 2.2789643825193777
Receivables turnover: 16.104622247089726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.200546726621225
FCF margin (%): 8.278367743743857
Revenue growth (%): -11.21203616110747
Rule of 40 score: -2.933668417363613
Financial ratios for ALMGI.PA — annual report dated 2024-12-31
Total revenue: 62113642.708333336
Gross profit: 18750216.666666668
Operating income: 1451784.375
Net income: 1442311.4583333335
Capital expenditures: 686458.3333333334
Operating cash flow: 9201041.666666668
Depreciation & amortization: 1118885.4166666667
Net tangible assets: 26459970.833333336
Owner earnings: 1874738.5416666665
Return on net tangible assets (%): 7.085187483672269
Capex to operating income (%): 47.283766456939134
Buffett classification: The Good
Stock price: 4.583333333333334
P/E ratio: 16.397436695581963
Shares outstanding: 5160046
Book value: 34079762.5
P/B ratio: 0.6939664216654484
Market cap (USD): 23650210.833333336
Debt to equity: 0.06266811816347997
Current ratio: 7.959302294016972
Quick ratio: 2.5960893837285837
Effective tax rate (%): -0.137844946854481
Interest coverage ratio: 13.531194174757282
COGS to revenue (%): 69.81304613752577
Free cash flow (dilution-adjusted): 8514583.333333334
Buyback yield (%): 0
Retained earnings: 23854737.5
Inventory turnover: 1.2769742785424252
Receivables turnover: 16.549327484317033
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.683611560236861
FCF margin (%): 13.708072755151735
Revenue growth (%): -20.66181748349258
Rule of 40 score: -6.953744728340846
Financial ratios for ALMGI.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 26459970.833333336
Buffett classification: The Gruesome
Stock price: 4.583333333333334
Shares outstanding: 5160046
Book value: 34079762.5
P/B ratio: 0.6939664216654484
Market cap (USD): 23650210.833333336
Debt to equity: 0.06266811816347997
Current ratio: 7.959302294016972
Quick ratio: 2.5960893837285837
Buyback yield (%): 0
Retained earnings: 23854737.5
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALMGI.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 31225688.23529412
Buffett classification: The Gruesome
Stock price: 4.1647058823529415
Shares outstanding: 5160046
Market cap (USD): 21490073.929411765
Quick ratio: -0.9372337956992475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMAL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.45
Shares outstanding: 29867347
Market cap (USD): 461450511.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMAL — annual report dated 2022-12-31
Total revenue: 266510000
Net income: 81477000
Capital expenditures: 1668000
Operating cash flow: 147322000
Depreciation & amortization: 10350000
Net tangible assets: 492781000
Owner earnings: 90159000
Return on net tangible assets (%): 18.29595702756397
Buffett classification: The Gruesome
Stock price: 21.59
P/E ratio: 7.914331918578249
Shares outstanding: 29867347
Book value: 508955000
P/B ratio: 1.266980424064996
Market cap (USD): 644836021.73
Debt to equity: 1.3723944160092738
Effective tax rate (%): 24.672719204171443
COGS to revenue (%): 0
SG&A to revenue (%): 30.64838092379273
Free cash flow (dilution-adjusted): 142972000
Buyback yield (%): 1.9350655948970352
Retained earnings: 330275000
Receivables turnover: 6.431070678796361
Capitalized R&D asset: 0
FCF margin (%): 53.646017035008065
Rule of 40 score: 53.646017035008065
Financial ratios for AMAL — annual report dated 2023-12-31
Total revenue: 285715000
Net income: 87978000
Capital expenditures: 1477000
Operating cash flow: 117224000
Depreciation & amortization: 6397000
Net tangible assets: 570078000
Owner earnings: 92898000
Return on net tangible assets (%): 16.295664803763696
Buffett classification: The Gruesome
Stock price: 25.79
P/E ratio: 8.755357920502853
Shares outstanding: 29867347
Book value: 585364000
P/B ratio: 1.3158972521883818
Market cap (USD): 770278879.13
Debt to equity: 0.5732723570291306
Effective tax rate (%): 29.46524492904674
COGS to revenue (%): 0
SG&A to revenue (%): 32.890467773830565
Free cash flow (dilution-adjusted): 111060000
Buyback yield (%): 1.0794791633637246
Retained earnings: 388033000
Receivables turnover: 5.149502559296374
Capitalized R&D asset: 0
FCF margin (%): 38.87090282274294
Revenue growth (%): 7.206108588795917
Rule of 40 score: 46.07701141153886
Financial ratios for AMAL — quarterly report dated 2024-09-30
Capital expenditures: 585000
Buffett classification: The Gruesome
Stock price: 30.42
Shares outstanding: 29867347
Market cap (USD): 908564695.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMAL — annual report dated 2024-12-31
Total revenue: 316476000
Net income: 106434000
Capital expenditures: 1775000
Operating cash flow: 124065000
Depreciation & amortization: 5433000
Net tangible assets: 693218000
Owner earnings: 110092000
Return on net tangible assets (%): 15.881295638601422
Buffett classification: The Gruesome
Stock price: 32.57
P/E ratio: 9.139743801698705
Shares outstanding: 29867347
Book value: 707654000
P/B ratio: 1.3746541272853683
Market cap (USD): 972779491.79
Debt to equity: 0.47217142840992915
Effective tax rate (%): 26.89420217186738
COGS to revenue (%): 0
SG&A to revenue (%): 31.980940102883
Free cash flow (dilution-adjusted): 116756000
Buyback yield (%): 0.13178731776520156
Retained earnings: 480144000
Receivables turnover: 5.173543451252207
Capitalized R&D asset: 0
FCF margin (%): 36.892528975340944
Revenue growth (%): 10.766323084192289
Rule of 40 score: 47.65885205953323
Financial ratios for AMAL — quarterly report dated 2024-12-31
Capital expenditures: 738000
Buffett classification: The Gruesome
Stock price: 32.57
Shares outstanding: 29867347
Market cap (USD): 972779491.79
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMAL — quarterly report dated 2025-03-31
Total revenue: 79491000
Net income: 25028000
Capital expenditures: 1753000
Operating cash flow: 34214000
Depreciation & amortization: 773000
Net tangible assets: 721760000
Owner earnings: 24048000
Return on net tangible assets (%): 3.331855464420306
Buffett classification: The Gruesome
Stock price: 28.09
P/E ratio: 8.380351778308295
Shares outstanding: 29867347
Book value: 735996000
P/B ratio: 1.1399162186071663
Market cap (USD): 838973777.23
Debt to equity: 0.11802509796248893
Effective tax rate (%): 27.950024469585742
COGS to revenue (%): 0
SG&A to revenue (%): 30.5254682920079
Free cash flow (dilution-adjusted): 31024000
Buyback yield (%): 0.41836826075646855
Retained earnings: 500783000
Receivables turnover: 1.442877368764975
Capitalized R&D asset: 0
FCF margin (%): 39.0283176711829
Rule of 40 score: 39.0283176711829
Financial ratios for AMAL — quarterly report dated 2025-06-30
Total revenue: 80883000
Net income: 25989000
Capital expenditures: 712000
Operating cash flow: 24925000
Depreciation & amortization: 714000
Net tangible assets: 739848000
Owner earnings: 25991000
Return on net tangible assets (%): 3.5130188903666695
Buffett classification: The Gruesome
Stock price: 30.63
P/E ratio: 17.93199989434894
Shares outstanding: 29867347
Book value: 753984000
P/B ratio: 1.2133372042510187
Market cap (USD): 914836838.61
Debt to equity: 0.12049592564298446
Effective tax rate (%): 26.70896785109983
COGS to revenue (%): 0
SG&A to revenue (%): 30.354957160342718
Free cash flow (dilution-adjusted): 23917000
Buyback yield (%): 1.0578935599822064
Retained earnings: 522405000
Receivables turnover: 1.45711506242231
Capitalized R&D asset: 0
FCF margin (%): 29.569872531928837
Revenue growth (%): 1.7511416386760765
Rule of 40 score: 31.321014170604915
Financial ratios for AMAL — quarterly report dated 2025-09-30
Total revenue: 85011000
Net income: 26790000
Capital expenditures: 1193000
Operating cash flow: 39499000
Depreciation & amortization: 726000
Net tangible assets: 761537000
Owner earnings: 26323000
Return on net tangible assets (%): 3.4565621893617773
Buffett classification: The Gruesome
Stock price: 26.78
P/E ratio: 10.279891946225918
Shares outstanding: 29867347
Book value: 775573000
P/B ratio: 1.031298862466847
Market cap (USD): 799847552.6600001
Debt to equity: 0.11640167979029697
Effective tax rate (%): 26.98282910874898
COGS to revenue (%): 0
SG&A to revenue (%): 31.70883767982967
Free cash flow (dilution-adjusted): 36528000
Buyback yield (%): 1.305748822418357
Retained earnings: 544901000
Receivables turnover: 1.489748352726763
Capitalized R&D asset: 0
FCF margin (%): 42.96855701026926
Revenue growth (%): 5.103668261562999
Rule of 40 score: 48.07222527183226
Financial ratios for AMAL — annual report dated 2025-12-31
Total revenue: 330457000
Net income: 104447000
Capital expenditures: 1379000
Operating cash flow: 135782000
Depreciation & amortization: 6796000
Net tangible assets: 780628000
Owner earnings: 109864000
Return on net tangible assets (%): 14.073796994214916
Buffett classification: The Gruesome
Stock price: 31.76
P/E ratio: 9.0819931708905
Shares outstanding: 29867347
Book value: 794464000
P/B ratio: 1.1939961291134653
Market cap (USD): 948586940.72
Debt to equity: 0.10303172956861481
Effective tax rate (%): 25.477507045770754
COGS to revenue (%): 0
SG&A to revenue (%): 31.67825163334413
Free cash flow (dilution-adjusted): 127485000
Buyback yield (%): 3.4099141166173568
Retained earnings: 567269000
Receivables turnover: 5.073962043974942
Capitalized R&D asset: 0
FCF margin (%): 38.57839295278962
Revenue growth (%): 4.417712559562179
Rule of 40 score: 42.9961055123518
Financial ratios for AMAL — quarterly report dated 2025-12-31
Total revenue: 85071000
Net income: 26640000
Capital expenditures: 855000
Operating cash flow: 37144000
Depreciation & amortization: 5648000
Net tangible assets: 780628000
Owner earnings: 31433000
Return on net tangible assets (%): 4.0266298416146995
Buffett classification: The Gruesome
Stock price: 31.76
P/E ratio: 9.0819931708905
Shares outstanding: 29867347
Book value: 794464000
P/B ratio: 1.1939961291134653
Market cap (USD): 948586940.72
Debt to equity: 0.10303172956861481
Effective tax rate (%): 19.923049176385714
COGS to revenue (%): 0
SG&A to revenue (%): 33.983378589648645
Free cash flow (dilution-adjusted): 36016000
Buyback yield (%): 0.9186295558091773
Retained earnings: 567269000
Receivables turnover: 1.3062123817712812
Capitalized R&D asset: 0
FCF margin (%): 42.33640135886495
Revenue growth (%): 0.07057910152803755
Rule of 40 score: 42.40698046039299
Financial ratios for AMR — annual report dated 2021-12-31
Capital expenditures: 8224000
Buffett classification: The Gruesome
Stock price: 57.96
Shares outstanding: 12714624
Market cap (USD): 736939607.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMR — annual report dated 2022-12-31
Total revenue: 4101592000
Gross profit: 1688505000
Operating income: 1580879000
Net income: 1448545000
Capital expenditures: 164309000
Operating cash flow: 1484005000
Depreciation & amortization: 127118000
Net tangible assets: 1363917000
Owner earnings: 1411354000
Return on net tangible assets (%): 103.47799756143519
Capex to operating income (%): 10.393521578817861
Buffett classification: The Great
Stock price: 144.92
P/E ratio: 1.2720373271662253
Shares outstanding: 12714624
Book value: 1429755000
P/B ratio: 1.2887545838832526
Market cap (USD): 1842603310.08
Debt to equity: 0.007676140317746747
Current ratio: 2.767888233467867
Quick ratio: 2.2697224464452033
Effective tax rate (%): 6.831001768773115
Interest coverage ratio: 72.51073296027887
COGS to revenue (%): 58.832936089206335
SG&A to revenue (%): 1.746102488984765
Free cash flow (dilution-adjusted): 1312212000
Buyback yield (%): 28.31879206693409
Retained earnings: 1275319000
Inventory turnover: 12.030906298922094
Receivables turnover: 10.072424547530758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 82.77486132447821
FCF margin (%): 31.99274818168165
Rule of 40 score: 31.99274818168165
Financial ratios for AMR — annual report dated 2023-12-31
Total revenue: 3471417000
Gross profit: 969887000
Operating income: 863085000
Net income: 721956000
Capital expenditures: 245373000
Operating cash flow: 851159000
Depreciation & amortization: 145392000
Net tangible assets: 1516225000
Owner earnings: 621975000
Return on net tangible assets (%): 41.02128641857244
Capex to operating income (%): 28.42976068405777
Buffett classification: The Good
Stock price: 338.92
P/E ratio: 5.968840713395276
Shares outstanding: 12714624
Book value: 1573928000
P/B ratio: 2.7378891322093515
Market cap (USD): 4309240366.08
Debt to equity: 0.006591152835453719
Current ratio: 3.382366986093634
Quick ratio: 2.63592746749266
Effective tax rate (%): 14.6078047545771
Interest coverage ratio: 124.66921854687274
COGS to revenue (%): 72.0607751820078
SG&A to revenue (%): 2.373382396871364
Free cash flow (dilution-adjusted): 586769000
Buyback yield (%): 12.53285855788286
Retained earnings: 1969527000
Inventory turnover: 10.813031675772875
Receivables turnover: 6.810946825667769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 41.175224592784694
FCF margin (%): 16.90286704247862
Revenue growth (%): -15.364156161802539
Rule of 40 score: 1.5387108806760796
Financial ratios for AMR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 236.18
Shares outstanding: 12714624
Market cap (USD): 3002939896.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 200.12
Shares outstanding: 12714624
Market cap (USD): 2544450554.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMR — annual report dated 2024-12-31
Total revenue: 2957285000
Gross profit: 331653000
Operating income: 227854000
Net income: 187579000
Capital expenditures: 198848000
Operating cash flow: 579919000
Depreciation & amortization: 174031000
Net tangible assets: 1598494000
Owner earnings: 162762000
Return on net tangible assets (%): 10.182209004225227
Capex to operating income (%): 87.26991845655552
Buffett classification: The Gruesome
Stock price: 200.12
P/E ratio: 13.564687704273933
Shares outstanding: 12714624
Book value: 1649497000
P/B ratio: 1.542561492915719
Market cap (USD): 2544450554.88
Debt to equity: 0.003506523503831774
Current ratio: 4.128362583579243
Quick ratio: 3.454276827991032
Effective tax rate (%): 10.994543297746144
Interest coverage ratio: 59.7885069535555
COGS to revenue (%): 88.78522022733691
SG&A to revenue (%): 2.5022951795312256
Free cash flow (dilution-adjusted): 368753000
Buyback yield (%): 4.806499374312573
Retained earnings: 2156467000
Inventory turnover: 15.511593971725478
Receivables turnover: 8.16611485581583
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.415711471800819
FCF margin (%): 12.469308842401054
Revenue growth (%): -14.810436199396385
Rule of 40 score: -2.3411273569953313
Financial ratios for AMR — quarterly report dated 2025-03-31
Total revenue: 531957000
Gross profit: -17894000
Operating income: -40175000
Net income: -33947000
Capital expenditures: 38450000
Operating cash flow: 22181000
Depreciation & amortization: 45267000
Net tangible assets: 1576316000
Owner earnings: -27130000
Return on net tangible assets (%): -1.7211016065306703
Buffett classification: The Gruesome
Stock price: 125.25
Shares outstanding: 12714624
Book value: 1614838000
P/B ratio: 0.9861711552490094
Market cap (USD): 1592506656
Debt to equity: 0.0031173405629543027
Current ratio: 3.872792198557025
Quick ratio: 3.1421064972305186
Interest coverage ratio: -52.65399737876802
COGS to revenue (%): 103.36380572113913
SG&A to revenue (%): 2.899482476967123
Free cash flow (dilution-adjusted): -19706000
Buyback yield (%): 0.3237035136134464
Retained earnings: 2122439000
Inventory turnover: 2.8925368109293874
Receivables turnover: 1.5554707580024036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8770355966310073
FCF margin (%): -3.7044347569446403
Rule of 40 score: -3.7044347569446403
Financial ratios for AMR — quarterly report dated 2025-06-30
Total revenue: 550274000
Gross profit: 24142000
Operating income: 2655000
Net income: -4954000
Capital expenditures: 34642000
Operating cash flow: 53231000
Depreciation & amortization: 46179000
Net tangible assets: 1576545000
Owner earnings: 6583000
Capex to operating income (%): 1304.783427495292
Buffett classification: The Gruesome
Stock price: 112.48
Shares outstanding: 12714624
Book value: 1613710000
P/B ratio: 0.8862440633818964
Market cap (USD): 1430140907.52
Debt to equity: 0.0035749917891070887
Current ratio: 4.061070678595058
Quick ratio: 3.2093810742949196
Interest coverage ratio: 3.488830486202365
COGS to revenue (%): 95.61273111213686
SG&A to revenue (%): 2.765167898174364
Free cash flow (dilution-adjusted): 14571000
Buyback yield (%): 0
Retained earnings: 2117485000
Inventory turnover: 2.5386222503148357
Receivables turnover: 1.858744924775204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.12466117281043566
FCF margin (%): 2.647953564951279
Revenue growth (%): 3.4433234265175567
Rule of 40 score: 6.091276991468836
Financial ratios for AMR — quarterly report dated 2025-09-30
Total revenue: 526778000
Gross profit: 19887000
Operating income: -2522000
Net income: -5515000
Capital expenditures: 25104000
Operating cash flow: 50548000
Depreciation & amortization: 45256000
Net tangible assets: 1556316000
Owner earnings: 14637000
Buffett classification: The Gruesome
Stock price: 164.09
Shares outstanding: 12714624
Book value: 1592124000
P/B ratio: 1.3104146738319378
Market cap (USD): 2086342652.16
Debt to equity: 0.003123500430870962
Current ratio: 3.951320174825873
Quick ratio: 3.1129941924282036
Interest coverage ratio: -3.2967320261437907
COGS to revenue (%): 96.22478539346746
SG&A to revenue (%): 2.979813128110893
Free cash flow (dilution-adjusted): 22494000
Buyback yield (%): 0.9585194445071608
Retained earnings: 2111970000
Inventory turnover: 2.4134218921106507
Receivables turnover: 1.8216140700320214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.12039542401912579
FCF margin (%): 4.2701099894073025
Revenue growth (%): -4.269872826991644
Rule of 40 score: 0.0002371624156580765
Financial ratios for AMR — annual report dated 2025-12-31
Total revenue: 2129481000
Gross profit: 24839000
Operating income: -61366000
Net income: -61687000
Capital expenditures: 127153000
Operating cash flow: 144926000
Depreciation & amortization: 179951000
Net tangible assets: 1499919000
Owner earnings: -8889000
Return on net tangible assets (%): -0.592632002128115
Buffett classification: The Gruesome
Stock price: 199.88
Shares outstanding: 12714624
Book value: 1545495000
P/B ratio: 1.64439163188493
Market cap (USD): 2541399045.12
Debt to equity: 0.008680713946017295
Current ratio: 4.4681737234943215
Quick ratio: 3.529101507381205
Interest coverage ratio: -20.326598211328253
COGS to revenue (%): 98.83356554954
SG&A to revenue (%): 2.8250075957475085
Free cash flow (dilution-adjusted): 4175000
Buyback yield (%): 1.7767772474262447
Retained earnings: 2094701000
Inventory turnover: 10.904880829015545
Receivables turnover: 7.642958150886512
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.957249371597761
FCF margin (%): 0.1960571613458866
Revenue growth (%): -27.992026470225223
Rule of 40 score: -27.795969308879336
Financial ratios for AMR — quarterly report dated 2025-12-31
Total revenue: 520472000
Gross profit: -1296000
Operating income: -21324000
Net income: -17271000
Capital expenditures: 28957000
Operating cash flow: 18966000
Depreciation & amortization: 43249000
Net tangible assets: 1499919000
Owner earnings: -2979000
Return on net tangible assets (%): -0.19861072497914886
Buffett classification: The Gruesome
Stock price: 199.88
Shares outstanding: 12714624
Book value: 1545495000
P/B ratio: 1.64439163188493
Market cap (USD): 2541399045.12
Debt to equity: 0.008680713946017295
Current ratio: 4.4681737234943215
Quick ratio: 3.529101507381205
Interest coverage ratio: -29.21095890410959
COGS to revenue (%): 100.24900474953505
SG&A to revenue (%): 2.655474261823883
Free cash flow (dilution-adjusted): -13184000
Buyback yield (%): 0.7870468055147769
Retained earnings: 2094701000
Inventory turnover: 2.703461139896373
Receivables turnover: 1.8680353169191013
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.027611146236526
FCF margin (%): -2.5330853532947017
Revenue growth (%): -1.1970887166890039
Rule of 40 score: -3.730174069983706
Financial ratios for AVD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.08
Shares outstanding: 28605895
Market cap (USD): 459982791.59999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVD — annual report dated 2022-12-31
Total revenue: 609615000
Gross profit: 192388000
Operating income: 40651000
Net income: 27404000
Capital expenditures: 84000
Operating cash flow: 57105000
Depreciation & amortization: 22138000
Net tangible assets: 138305000
Owner earnings: 49458000
Return on net tangible assets (%): 35.76009544123495
Capex to operating income (%): 0.20663698310004674
Buffett classification: The Great
Stock price: 21.4
P/E ratio: 22.33856929645307
Shares outstanding: 28605895
Book value: 369979000
P/B ratio: 1.6545970257771385
Market cap (USD): 612166153
Debt to equity: 0.2060873725265488
Current ratio: 1.457485155719596
Quick ratio: 0.766602525871996
Effective tax rate (%): 23.803698039760878
Interest coverage ratio: 10.280981284774912
COGS to revenue (%): 68.44106526250174
R&D to revenue (%): 5.219031683931662
SG&A to revenue (%): 19.67159600731609
Free cash flow (dilution-adjusted): 36867000
Buyback yield (%): 5.892027813566491
Retained earnings: 328745000
Inventory turnover: 2.265198979314838
Receivables turnover: 3.6243675646109668
Capitalized R&D asset: 31816000
ROCI (R&D-adjusted, %): 12.585583459470604
FCF margin (%): 6.047587411727074
Rule of 40 score: 6.047587411727074
Financial ratios for AVD — annual report dated 2023-12-31
Total revenue: 579371000
Gross profit: 179164000
Operating income: 24252000
Net income: 7519000
Capital expenditures: 242000
Operating cash flow: -58748000
Depreciation & amortization: 21780000
Net tangible assets: 146303000
Owner earnings: 29057000
Return on net tangible assets (%): 19.860836756594193
Capex to operating income (%): 0.9978558469404585
Buffett classification: The Great
Stock price: 10.91
P/E ratio: 41.50689113578933
Shares outstanding: 28605895
Book value: 370010000
P/B ratio: 0.8434645400124321
Market cap (USD): 312090314.45
Debt to equity: 0.43808005189048943
Current ratio: 1.8743183149309095
Quick ratio: 0.9217987374997288
Effective tax rate (%): 26.978731669418277
Interest coverage ratio: 1.9188226916686446
COGS to revenue (%): 69.07611875637545
R&D to revenue (%): 6.5631521080620185
SG&A to revenue (%): 20.174810268377257
Free cash flow (dilution-adjusted): -76950000
Buyback yield (%): 5.609273722848787
Retained earnings: 332897000
Inventory turnover: 1.822842984090257
Receivables turnover: 2.974290657261811
Capitalized R&D asset: 59341720
ROCI (R&D-adjusted, %): 6.538734391657034
Rosenberg metric: -0.41563992959517226
FCF margin (%): -13.281645094421362
Revenue growth (%): -4.96116401335269
Rule of 40 score: -18.24280910777405
Financial ratios for AVD — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 2290000
Buffett classification: The Gruesome
Stock price: 5.3
Shares outstanding: 28605895
Market cap (USD): 151611243.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVD — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 15667000
Buffett classification: The Gruesome
Stock price: 4.63
Shares outstanding: 28605895
Market cap (USD): 132445293.85
Buyback yield (%): 1.0812011196274
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVD — annual report dated 2024-12-31
Total revenue: 547306000
Gross profit: 120317000
Operating income: -30794000
Net income: -126340000
Capital expenditures: 1065000
Operating cash flow: 3923000
Depreciation & amortization: 22322000
Net tangible assets: 62912000
Owner earnings: -105083000
Return on net tangible assets (%): -167.03172685656153
Buffett classification: The Gruesome
Stock price: 4.63
Shares outstanding: 28605895
Book value: 233110000
P/B ratio: 0.568166504439964
Market cap (USD): 132445293.85
Debt to equity: 0.7198618677877396
Current ratio: 1.6306993759414676
Quick ratio: 0.8590531525715516
Interest coverage ratio: -1.861001994319212
COGS to revenue (%): 78.01650265116771
R&D to revenue (%): 5.967776709920958
SG&A to revenue (%): 19.204978567748206
Free cash flow (dilution-adjusted): -8177000
Buyback yield (%): 1.0812011196274
Retained earnings: 204882000
Inventory turnover: 2.3815284563728443
Receivables turnover: 3.049534189177142
Capitalized R&D asset: 68638030
ROCI (R&D-adjusted, %): -6.82855180728086
Rosenberg metric: -1.5475871137409598
FCF margin (%): -1.4940453786364483
Revenue growth (%): -5.534450291781949
Rule of 40 score: -7.028495670418398
Financial ratios for AVD — quarterly report dated 2025-03-31
Total revenue: 115800000
Gross profit: 30191000
Operating income: -4310000
Net income: -8462000
Capital expenditures: 12000
Operating cash flow: -20576000
Depreciation & amortization: 4744000
Net tangible assets: 59395000
Owner earnings: -3730000
Return on net tangible assets (%): -6.279989898139574
Buffett classification: The Gruesome
Stock price: 4.4
Shares outstanding: 28605895
Book value: 227354000
P/B ratio: 0.5536121554931958
Market cap (USD): 125865938.00000001
Debt to equity: 0.8205617671120807
Current ratio: 1.773393096003567
Quick ratio: 0.9070095980099969
Interest coverage ratio: -1.2206173888416878
COGS to revenue (%): 73.92832469775476
R&D to revenue (%): 4.9067357512953365
SG&A to revenue (%): 22.243523316062173
Free cash flow (dilution-adjusted): -21593000
Buyback yield (%): 0.008739457374083208
Retained earnings: 196420000
Inventory turnover: 0.463764111898416
Receivables turnover: 0.6695963918121892
Capitalized R&D asset: 5682000
ROCI (R&D-adjusted, %): -0.12305371223818673
FCF margin (%): -18.64680483592401
Rule of 40 score: -18.64680483592401
Financial ratios for AVD — quarterly report dated 2025-06-30
Total revenue: 129313000
Gross profit: 40547000
Operating income: 6271000
Net income: -849000
Capital expenditures: 39000
Operating cash flow: -19260000
Depreciation & amortization: 4703000
Net tangible assets: 63849000
Owner earnings: 3815000
Capex to operating income (%): 0.6219103811194387
Buffett classification: The Great
Stock price: 3.92
Shares outstanding: 28605895
Book value: 230822000
P/B ratio: 0.4858077150358284
Market cap (USD): 112135108.39999999
Debt to equity: 0.9034234171786052
Current ratio: 1.9129939064116812
Quick ratio: 0.9956166404782892
Interest coverage ratio: 1.523936816524909
COGS to revenue (%): 68.64429717043143
R&D to revenue (%): 4.487561188743591
SG&A to revenue (%): 19.66082296443513
Free cash flow (dilution-adjusted): -20332000
Buyback yield (%): 0
Retained earnings: 195571000
Inventory turnover: 0.46353728779040926
Receivables turnover: 0.7029561416860554
Capitalized R&D asset: 9609940
ROCI (R&D-adjusted, %): 1.8208627605056755
Rosenberg metric: 1.82259767687434
FCF margin (%): -15.723090485875357
Revenue growth (%): 11.669257340241797
Rule of 40 score: -4.0538331456335595
Financial ratios for AVD — quarterly report dated 2025-09-30
Total revenue: 119313000
Gross profit: 34214000
Operating income: 1813000
Net income: -12358000
Capital expenditures: 441000
Operating cash flow: 12692000
Depreciation & amortization: 4576000
Net tangible assets: 56541000
Owner earnings: -8223000
Return on net tangible assets (%): -14.543428662386587
Capex to operating income (%): 24.324324324324326
Buffett classification: The Great
Stock price: 5.74
Shares outstanding: 28605895
Book value: 220988000
P/B ratio: 0.7430169841801365
Market cap (USD): 164197837.3
Debt to equity: 0.9076918203703368
Current ratio: 1.7659699261840316
Quick ratio: 0.9013585787710662
Interest coverage ratio: 0.41938468656025907
COGS to revenue (%): 71.32416417322504
R&D to revenue (%): 4.738796275343005
SG&A to revenue (%): 19.848633426365943
Free cash flow (dilution-adjusted): 10506000
Buyback yield (%): 0
Retained earnings: 183213000
Inventory turnover: 0.4276224215471973
Receivables turnover: 0.6607173512163517
Capitalized R&D asset: 11417070
ROCI (R&D-adjusted, %): 0.40205099184764825
Rosenberg metric: -1.0913320696191624
FCF margin (%): 8.805410977848181
Revenue growth (%): -7.733174545482665
Rule of 40 score: 1.072236432365516
Financial ratios for AVD — quarterly report dated 2025-12-31
Total revenue: 150688000
Gross profit: 42609000
Operating income: 7952000
Net income: -28213000
Capital expenditures: 15000
Operating cash flow: 5953000
Depreciation & amortization: 4735000
Net tangible assets: 53651000
Owner earnings: -23493000
Return on net tangible assets (%): -43.78855939311476
Capex to operating income (%): 0.1886317907444668
Buffett classification: The Great
Stock price: 3.82
Shares outstanding: 28605895
Book value: 192397000
P/B ratio: 0.5679637359210382
Market cap (USD): 109274518.89999999
Debt to equity: 0.9947452403103999
Current ratio: 1.7690574181411916
Quick ratio: 0.9285830237865608
Interest coverage ratio: 1.6911952360697575
COGS to revenue (%): 71.72369399023147
R&D to revenue (%): 3.996336801868762
SG&A to revenue (%): 17.04979825865364
Free cash flow (dilution-adjusted): 4128000
Buyback yield (%): 0
Retained earnings: 155000000
Inventory turnover: 0.6139666200847563
Receivables turnover: 0.8740856753386119
Capitalized R&D asset: 11725170
ROCI (R&D-adjusted, %): 2.042962968795038
Rosenberg metric: 1.4847895295366111
FCF margin (%): 2.7394351242301975
Revenue growth (%): 26.296380109459992
Rule of 40 score: 29.03581523369019
Financial ratios for AVD — annual report dated 2025-12-31
Total revenue: 515114000
Gross profit: 147561000
Operating income: 13767000
Net income: -49882000
Capital expenditures: 477000
Operating cash flow: -21191000
Depreciation & amortization: 18742000
Net tangible assets: 53651000
Owner earnings: -31617000
Return on net tangible assets (%): -58.93086801737153
Capex to operating income (%): 3.464807147526694
Buffett classification: The Great
Stock price: 3.82
Shares outstanding: 28605895
Book value: 192397000
P/B ratio: 0.5679637359210382
Market cap (USD): 109274518.89999999
Debt to equity: 0.9947452403103999
Current ratio: 1.7690574181411916
Quick ratio: 0.9285830237865608
Interest coverage ratio: 0.8258548290341932
COGS to revenue (%): 71.35371975912128
R&D to revenue (%): 4.496286258964035
SG&A to revenue (%): 19.123922083267004
Free cash flow (dilution-adjusted): -27291000
Buyback yield (%): 0
Retained earnings: 155000000
Inventory turnover: 2.087965961121147
Receivables turnover: 2.9879868905710723
Capitalized R&D asset: 57592790
ROCI (R&D-adjusted, %): 1.2695163305443025
Rosenberg metric: 0.8341191598799829
FCF margin (%): -5.298050528620849
Revenue growth (%): -5.881901532232426
Rule of 40 score: -11.179952060853275
Financial ratios for BHRB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.72
Shares outstanding: 20149806
Market cap (USD): 941398936.3199999
Buyback yield (%): 0.11844075417788551
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHRB — annual report dated 2022-12-31
Total revenue: 118535000
Net income: 44013000
Capital expenditures: 14815000
Operating cash flow: 61057000
Depreciation & amortization: 3053000
Net tangible assets: 273453000
Owner earnings: 32251000
Return on net tangible assets (%): 11.793982878227704
Buffett classification: The Gruesome
Stock price: 62.3
P/E ratio: 28.52186658032854
Shares outstanding: 20149806
Book value: 273453000
P/B ratio: 4.590671573542802
Market cap (USD): 1255332913.8
Debt to equity: 1.2546945910266116
Effective tax rate (%): 15.843515172374234
COGS to revenue (%): 0
SG&A to revenue (%): 43.33150546252162
Free cash flow (dilution-adjusted): 35982000
Buyback yield (%): 0
Retained earnings: 424391000
Receivables turnover: 7.656805115948582
Capitalized R&D asset: 0
FCF margin (%): 30.355591175602143
Rule of 40 score: 30.355591175602143
Financial ratios for BHRB — annual report dated 2023-12-31
Total revenue: 109145000
Net income: 22692000
Capital expenditures: 10866000
Operating cash flow: 42509000
Depreciation & amortization: 2872000
Net tangible assets: 314750000
Owner earnings: 14698000
Return on net tangible assets (%): 4.669737887212073
Buffett classification: The Gruesome
Stock price: 57.45
P/E ratio: 51.013853106821784
Shares outstanding: 20149806
Book value: 314750000
P/B ratio: 3.6778597448768866
Market cap (USD): 1157606354.7
Debt to equity: 0.8641779189833201
Effective tax rate (%): 9.452934838992858
COGS to revenue (%): 0
SG&A to revenue (%): 48.542764212744515
Free cash flow (dilution-adjusted): 25796000
Buyback yield (%): 0
Retained earnings: 427333000
Receivables turnover: 6.866624724756212
Capitalized R&D asset: 0
FCF margin (%): 23.63461450364194
Revenue growth (%): -7.921710887079765
Rule of 40 score: 15.712903616562176
Financial ratios for BHRB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 59.13
Shares outstanding: 20149806
Market cap (USD): 1191458028.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHRB — annual report dated 2024-12-31
Total revenue: 256553000
Net income: 35708000
Capital expenditures: 4567000
Operating cash flow: 85799000
Depreciation & amortization: 17407000
Net tangible assets: 640074000
Owner earnings: 48548000
Return on net tangible assets (%): 7.5847480135109375
Buffett classification: The Gruesome
Stock price: 59.13
P/E ratio: 33.36669734457265
Shares outstanding: 20149806
Book value: 730157000
P/B ratio: 1.6317833408157425
Market cap (USD): 1191458028.78
Debt to equity: 0.6531266563218595
Effective tax rate (%): 10.501779537821445
COGS to revenue (%): 0
SG&A to revenue (%): 39.55868767856934
Free cash flow (dilution-adjusted): 78353000
Buyback yield (%): 0
Retained earnings: 434106000
Receivables turnover: 7.4462471701398965
Capitalized R&D asset: 0
FCF margin (%): 30.540668010118765
Revenue growth (%): 135.05703422053233
Rule of 40 score: 165.5977022306511
Financial ratios for BHRB — quarterly report dated 2025-03-31
Total revenue: 81878000
Net income: 27201000
Capital expenditures: 1778000
Operating cash flow: 37647000
Depreciation & amortization: 5999000
Net tangible assets: 672156000
Owner earnings: 31422000
Return on net tangible assets (%): 4.6748076339421205
Buffett classification: The Gruesome
Stock price: 53.66
P/E ratio: 9.937489338259622
Shares outstanding: 20149806
Book value: 758000000
P/B ratio: 1.4264361345118732
Market cap (USD): 1081238589.96
Debt to equity: 0.5452361477572559
Effective tax rate (%): 17.183741817628253
COGS to revenue (%): 0
SG&A to revenue (%): 33.97860231075502
Free cash flow (dilution-adjusted): 34564000
Buyback yield (%): 0
Retained earnings: 452736000
Receivables turnover: 2.3745831037382907
Capitalized R&D asset: 0
FCF margin (%): 42.214025745621534
Rule of 40 score: 42.214025745621534
Financial ratios for BHRB — quarterly report dated 2025-06-30
Total revenue: 85796000
Net income: 29897000
Capital expenditures: 3426000
Operating cash flow: 41000
Depreciation & amortization: 5689000
Net tangible assets: 696755000
Owner earnings: 32160000
Return on net tangible assets (%): 4.615682700518834
Buffett classification: The Gruesome
Stock price: 57.68
P/E ratio: 9.718707646921095
Shares outstanding: 20149806
Book value: 780018000
P/B ratio: 1.4900179355861018
Market cap (USD): 1162240810.08
Debt to equity: 0.9803517354727711
Effective tax rate (%): 19.59065113902262
COGS to revenue (%): 0
SG&A to revenue (%): 31.90125413772204
Free cash flow (dilution-adjusted): -4550000
Buyback yield (%): 0
Retained earnings: 474019000
Receivables turnover: 2.4199926663469946
Capitalized R&D asset: 0
FCF margin (%): -5.303277542076554
Revenue growth (%): 4.785168177043895
Rule of 40 score: -0.5181093650326591